Navigation Links
Massachusetts General Hospital Center Reignites Methods in Bioengineering Conference
Date:5/2/2011

BOSTON, April 6, 2011 /PRNewswire/ -- The Center for Engineering in Medicine (CEM) -- a bioengineering research institute at the Massachusetts General Hospital (MGH), a Harvard Teaching Hospital -- has announced it will reconvene its popular "Methods in Bioengineering" conference in conjunction with event organizer Horizon House Ltd.  The event, BioMethods Boston, will take place at Harvard Medical School on July 14-15, and expects to draw over 400 senior researchers from the Boston biotech community.

BioMethods Boston has confirmed program participation from Harvard, MIT, Boston University, Northeastern, WPI, and Tufts, plus top-tier pharma companies like Millipore, Life Technologies, and Genzyme, as well as major health centers like Mass General Hospital and Children's Hospital Boston.

BioMethods Boston’s agenda will include sessions on stem cell therapies, functional imaging, BioMEMS, nanotechnologies, and gene delivery. A call for posters has just been announced, and an automated interface for submissions, as well as the nearly-complete agenda, can be accessed at the event website (www.biomethodsboston.com). "This event is designed to give biomedical investigators from all fields a clear perspective on the most advanced technologies, techniques, and methodologies, and an opportunity for attendees to network with top researchers in the field," says Dr. Martin Yarmush, Director of the CEM.

Yarmush is joined on the program committee by Dr. Robert Langer of MIT, named by Forbes' magazine as one of the 25 most important people in biotechnology, as well as Dr. James Burns, SVP, Drug & Biomaterial R&D at Genzyme Corp., Dr. Donald Ingber, Director, Wyss Institute for Biologically Inspired Engineering at Harvard, Dr. Joachim Kohn, Director, New Jersey Center for Biomaterials at Rutgers, Dr. Mehmet Toner, Director, BioMEMS Resource Center at MGH, Dr. Kyongbum Lee, Department Chair, Chemical & Biological Engineering at Tufts, and Dr. Mahendra Rao, VP, Stem Cells & Regenerative Medicine at Invitrogen/Life Technologies -- among many others.

About the Center for Engineering in Medicine (Boston, MA): The CEM is well known nationally and internationally as a stellar training venue for young bioengineers and a pre-eminent research enterprise pioneering new tools and techniques at the intersection of the molecular and cellular sciences and microsystems bioengineering.  

About Horizon House Ltd. (Norwood, MA): Horizon House manages conferences, trade-shows, Websites, and e-mail newsletters in various advanced technology industries. The privately-held company maintains headquarter offices in Norwood, MA and London.


'/>"/>
SOURCE Horizon House Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Massachusetts General Hospital Center Reignites Methods in Bioengineering Conference
2. Massachusetts General Hospitals Warren Triennial Prize to honor pioneers of cellular reprogramming
3. L-1 Identity Solutions Awarded New Massachusetts RMV Drivers License Contract Valued at an Estimated $32 Million
4. Boston Medical Center to receive $245,000 grant from Attorney General Martha Coakley
5. Entrust President and CEO Bill Conner Addresses Global Dignitaries During INTERPOL 79th General Assembly
6. General Manifolds LLC Announces Issuance of US Patent in Computational Neuroscience
7. Major moral decisions use general-purpose brain circuits to manage uncertainty
8. Mass. General researchers develop functional, transplantable rat liver grafts
9. Oil Refineries Announces Delay to Annual & Special General Meeting
10. American Society for Microbiology to host 110th general meeting in San Diego
11. Modern man found to be generally monogamous, moderately polygamous
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts from Austria, ... could be a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma ... read it now. , Biomarkers are components in the blood, tissue or ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology: